ViraShield Research
Mechanism-Based Evaluation of ViraShield
Mechanism-Based Evaluation of ViraShield
ViraShield is a research-oriented flavonoid formulation developed by AMH Biotech LLC using high-purity plant-derived compounds evaluated through computational and experimental methodologies.
Unlike conventional botanical supplements based primarily on crude extracts, ViraShield emphasizes:
- High-purity flavonoids
- Defined molecular targets
- Computational docking analysis
- Experimental binding validation
- Mechanism-based evaluation
TMPRSS2 and Viral Entry
One of the primary targets evaluated in the ViraShield research framework is TMPRSS2 (Transmembrane Serine Protease 2), a host protease involved in viral Spike protein activation.
Computational docking studies identified Hesperidin as a strong TMPRSS2-interacting flavonoid, demonstrating:
- Interaction with catalytic residues His296, Asp345, and Ser441
- Stable hydrogen bonding patterns
- Favorable binding geometry within the catalytic domain
Experimental fluorescence-based TMPRSS2 inhibition assays demonstrated dose-dependent protease inhibition by Hesperidin and Hesperetin.
Mpro Interaction
ViraShield-associated flavonoids were also evaluated against the SARS-CoV-2 main protease (Mpro), an enzyme essential for viral replication.
Docking analysis demonstrated:
- Stable pocket occupancy
- Multi-point hydrogen bonding
- Interaction with residues surrounding the protease pocket
These findings support the broader multi-target framework evaluated by AMH Biotech.
Influenza Viral Proteins
Additional computational analysis extended the research scope beyond SARS-CoV-2 to influenza viral proteins.
Flavonoid interactions were evaluated against:
- Hemagglutinin (HA)
- Neuraminidase (NA)
Hesperidin demonstrated moderate interaction with hemagglutinin, while Rutin demonstrated stronger binding within the neuraminidase catalytic pocket.
Experimental Validation
AMH Biotech integrated multiple orthogonal validation methods including:
- Surface Plasmon Resonance (SPR)
- TMPRSS2 enzyme inhibition assays
- Calu-3 cell viability studies
- LigPlot+ interaction mapping
Calu-3 Cell Studies
Calu-3 human lung epithelial cells expressing TMPRSS2 were used to evaluate Spike-associated toxicity and flavonoid protection.
Pre-treatment with Hesperidin and Rutin demonstrated partial restoration of cell viability in the experimental system without detectable intrinsic toxicity at tested concentrations.
Research Summary
The ViraShield research program supports a mechanism-based framework involving:
- TMPRSS2 interaction
- Mpro pocket binding
- Spike-associated interaction analysis
- Influenza HA and NA evaluation
- Experimental validation using SPR and cell-based assays
AMH - BIOTECH
